View all news

    Janssen Receives CHMP Positive Opinion for STELARA® (USTEKINUMAB) Recommending Approval for the Treatment of Moderately to Severely Active Ulcerative Colitis in the EU

    07/26/2019
    Download(opens in new window)PDF 565 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com